GI
DXCM icon

Gradient Investments’s DexCom DXCM Stock Holding History

Gradient Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.4M Sell
236,283
-136,259
-37% -$11.3M 0.29% 98
2026
Q2 		$25.1M Buy
372,542
+53,283
+17% +$3.55M 0.35% 90
2026
Q1 		$20M Sell
319,259
-12,747
-4% -$888K 0.31% 98
2025
Q4 		$22M Buy
332,006
+40,343
+14% +$2.61M 0.35% 88
2025
Q3 		$19.6M Buy
291,663
+21,915
+8% +$1.73M 0.33% 95
2025
Q2 		$23.5M Sell
269,748
-11,577
-4% -$907K 0.43% 79
2025
Q1 		$19.2M Buy
281,325
+26,782
+11% +$2.19M 0.39% 82
2024
Q4 		$19.8M Buy
254,543
+58,947
+30% +$4.36M 0.4% 73
2024
Q3 		$13.1M Buy
195,596
+27,657
+16% +$2.27M 0.27% 115
2024
Q2 		$19M Buy
167,939
+8,098
+5% +$1.02M 0.43% 71
2024
Q1 		$22.2M Buy
159,841
+7,002
+5% +$880K 0.51% 54
2023
Q4 		$19M Buy
152,839
+33,742
+28% +$3.45M 0.46% 62
2023
Q3 		$11.1M Buy
119,097
+10,596
+10% +$1.19M 0.29% 112
2023
Q2 		$13.9M Buy
108,501
+6,091
+6% +$737K 0.36% 99
2023
Q1 		$11.9M Buy
102,410
+13,584
+15% +$1.52M 0.32% 102
2022
Q4 		$10.1M Sell
88,826
-14,485
-14% -$1.59M 0.32% 104
2022
Q3 		$8.32M Sell
103,311
-28,137
-21% -$2.38M 0.25% 114
2022
Q2 		$9.8M Buy
131,448
+8,992
+7% +$821K 0.29% 103
2022
Q1 		$15.7M Buy
122,456
+16,572
+16% +$1.81M 0.4% 57
2021
Q4 		$14.2M Buy
105,884
+17,336
+20% +$2.49M 0.36% 67
2021
Q3 		$12.1M Sell
88,548
-2,864
-3% -$361K 0.34% 77
2021
Q2 		$9.76M Buy
91,412
+9,336
+11% +$897K 0.29% 106
2021
Q1 		$7.37M Buy
82,076
+81,408
+12,187% +$7.64M 0.24% 116
2020
Q4 		$69K Hold
668
– – ﹤0.01% 357
2020
Q3 		$69K Hold
668
– – ﹤0.01% 360
2020
Q2 		$68K Hold
668
– – ﹤0.01% 342
2020
Q1 		$45K Hold
668
– – ﹤0.01% 360
2019
Q4 		$37K Hold
668
– – ﹤0.01% 456
2019
Q3 		$25K Hold
668
– – ﹤0.01% 493
2019
Q2 		$25K Buy
+668
New +$21K ﹤0.01% 480

Other funds holding DXCM

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
HH
HWG Holdings Houston, Texas $434M AUM 42.17% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
BAM
Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return
AIC
Argus Investors Counsel New York $129M AUM 31.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
HAG
HF Advisory Group Annapolis, Maryland $336M AUM 14.9% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Gradient Investments's DXCM Position: Q3 2026 in Review

Gradient Investments reduced its DexCom (DXCM) stake by 37% in Q3 2026, selling an estimated $11.3M and leaving 236,283 shares worth $20.4M. The position accounts for 0.29% of the portfolio, ranked #98.

Gradient Investments first reported a position in DXCM in Q2 2019 and has held it in 30 quarters since. The position peaked at $25.1M in Q2 2026. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Gradient Investments held 236,283 shares of DexCom worth $20.4M as of Q3 2026.
  • Gradient Investments sold 136,259 DexCom shares in Q3 2026, an estimated $11.3M.
  • DexCom made up 0.29% of Gradient Investments's portfolio in Q3 2026, its #98 holding.
  • Gradient Investments first reported a position in DexCom in Q2 2019 and has held it in 30 quarters since.
  • Gradient Investments's DexCom position peaked at $25.1M in Q2 2026.
  • 41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Gradient Investments's 13F filing for Q3 2026, filed 8 Oct 2026.